Discover How Helix is Changing the World of Healthcare

Resources Hub

Screening Familial Risk for Hereditary Breast and Ovarian Cancer

Research

Sep 30, 2024

Screening Familial Risk for Hereditary Breast and Ovarian Cancer

Reduced Likelihood of Hospitalization With the JN.1 or HV.1 Severe Acute Respiratory Syndrome Coronavirus 2 Variants Compared With the EG.5 Variant

Research

Aug 6, 2024

Reduced Likelihood of Hospitalization With the JN.1 or HV.1 Severe Acute Respiratory Syndrome Coronavirus 2 Variants Compared With the EG.5 Variant

The Ohio State University Wexner Medical Center and Helix Partner to Launch the Largest Precision Health Initiative in Ohio

Press Releases

Jul 22, 2024

The Ohio State University Wexner Medical Center and Helix Partner to Launch the Largest Precision Health Initiative in Ohio

White Paper: Semaglutide and Weight Management

Research

Jul 12, 2024

White Paper: Semaglutide and Weight Management

Helix and Recursion Pharmaceuticals Drive Drug Discovery Innovation Through Clinico-Genomic Data

Press Releases

Jun 24, 2024

Helix and Recursion Pharmaceuticals Drive Drug Discovery Innovation Through Clinico-Genomic Data

Helix Launches Clinico-Genomic Datasets for Cardiovascular, Metabolic, Immunology and Inflammation Disorders

Press Releases

Jun 7, 2024

Helix Launches Clinico-Genomic Datasets for Cardiovascular, Metabolic, Immunology and Inflammation Disorders

Partner Perspectives with Nebraska Medicine

Videos

May 28, 2024

Partner Perspectives with Nebraska Medicine

The Future of Precision Medicine: Leveraging Clinico-Genomic Data for Germline Disorders

Webinars

Apr 25, 2024

The Future of Precision Medicine: Leveraging Clinico-Genomic Data for Germline Disorders

Population Genomics: Personalizing Genetic Breast Cancer Screening

Blog

Apr 16, 2024

Population Genomics: Personalizing Genetic Breast Cancer Screening

The Latest Content From Helix

Helix awarded "Best Overall Genomics Solution" by MedTech Breakthrough Awards

Recent Press Releases

View All Press Releases

Press Releases

Helix Expands Pharmacogenomic Test Portfolio to Support Safer Cancer and Alzheimer’s Treatments

May 28, 2025

Press Releases

Helix Launches 23,000-Patient Clinico-Genomic Cohort for Autoimmune Diseases to Advance Drug Discovery and Development

March 18, 2025

Press Releases

Helix Unveils Groundbreaking Real-World Insights at the ACMG Annual Clinical Genetics Meeting, Driving Clinical Care Forward

March 13, 2025

Recent Published Research

View All Published Research

Published Research

Chatbot for the Return of Positive Genetic Screening Results for Hereditary Cancer Syndromes: Prompt Engineering Project

June 10, 2025

Published Research

Individuals with PMS2 pathogenic variants are at average risk of cancer before age 60

March 19, 2025

Published Research

Scalable system-wide CYP2C19 pharmacogenomic testing reveals 38% excess incidence of adverse events in metabolizers receiving inappropriate prescriptions

March 19, 2025

Published Research

Population genomic screening leads to improved lipid management in patients with familial hypercholesterolemia

March 19, 2025

Published Research

Discover How Helix is Changing the World of Healthcare

Resources Hub

The Latest Content From Helix

Recent Blog Posts

Understanding Hidden Heart Risk: How Genetics Can Inform Your Lp(a) Levels

GLP-1 Spending Is Spiraling — But There's a Smarter Way Forward

Mental Health Awareness Month: Advancing Empathy and Personalization in Care

Helix awarded "Best Overall Genomics Solution" by MedTech Breakthrough Awards

Recent Press Releases

Helix Expands Pharmacogenomic Test Portfolio to Support Safer Cancer and Alzheimer’s Treatments

Helix Launches 23,000-Patient Clinico-Genomic Cohort for Autoimmune Diseases to Advance Drug Discovery and Development

Helix Unveils Groundbreaking Real-World Insights at the ACMG Annual Clinical Genetics Meeting, Driving Clinical Care Forward

Recent Videos

Partner Perspectives with Nebraska Medicine

Partner Perspectives with MUSC - Update

Partner Perspectives with Renown Health - Update

Recent Published Research

Chatbot for the Return of Positive Genetic Screening Results for Hereditary Cancer Syndromes: Prompt Engineering Project

Individuals with PMS2 pathogenic variants are at average risk of cancer before age 60

Scalable system-wide CYP2C19 pharmacogenomic testing reveals 38% excess incidence of adverse events in metabolizers receiving inappropriate prescriptions

Population genomic screening leads to improved lipid management in patients with familial hypercholesterolemia

Underestimated risk of secondary complications in pathogenic and glucose-elevating GCK variant carriers with type 2 diabetes

Recent Whitepapers

Performance and Applications of Helix Exome+®​ Assay

White Paper: Semaglutide and Weight Management

Technical Briefing 6: JN.1

Technical Briefing 5: SARS-CoV-2 Antiviral Treatment Gaps

Get in touch

The Latest Content From Helix

Recent Blog Posts

Understanding Hidden Heart Risk: How Genetics Can Inform Your Lp(a) Levels

GLP-1 Spending Is Spiraling — But There's a Smarter Way Forward

Mental Health Awareness Month: Advancing Empathy and Personalization in Care

Helix awarded "Best Overall Genomics Solution" by MedTech Breakthrough Awards

Recent Press Releases

Helix Expands Pharmacogenomic Test Portfolio to Support Safer Cancer and Alzheimer’s Treatments

Helix Launches 23,000-Patient Clinico-Genomic Cohort for Autoimmune Diseases to Advance Drug Discovery and Development

Helix Unveils Groundbreaking Real-World Insights at the ACMG Annual Clinical Genetics Meeting, Driving Clinical Care Forward

Recent Videos

Partner Perspectives with Nebraska Medicine

Partner Perspectives with MUSC - Update

Partner Perspectives with Renown Health - Update

Recent Published Research

Chatbot for the Return of Positive Genetic Screening Results for Hereditary Cancer Syndromes: Prompt Engineering Project

Individuals with PMS2 pathogenic variants are at average risk of cancer before age 60

Scalable system-wide CYP2C19 pharmacogenomic testing reveals 38% excess incidence of adverse events in metabolizers receiving inappropriate prescriptions

Population genomic screening leads to improved lipid management in patients with familial hypercholesterolemia

Underestimated risk of secondary complications in pathogenic and glucose-elevating GCK variant carriers with type 2 diabetes

Recent Whitepapers

Performance and Applications of Helix Exome+®​ Assay

White Paper: Semaglutide and Weight Management

Technical Briefing 6: JN.1

Technical Briefing 5: SARS-CoV-2 Antiviral Treatment Gaps

Performance and Applications of Helix Exome+^® Assay

Performance and Applications of Helix Exome+^® Assay